Birdwatch Note
2024-11-27 05:57:38 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
A GLP-1 inhibitor does not exist as a distinct medical term, but it might be a confusion or reference to GLP-1 receptor agonists, which are medications used to treat type 2 diabetes and obesity. They bind to the GLP-1 receptor and activate it, enhancing the hormone's effects. https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/expert-answers/byetta/faq-20057955
Written by 7192F7BB84387E03A0CE63281FCCE5162DBF8532F9DCB1AFF88F7F7291CB18B9
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1861643996818481289
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1861650570614018263
- noteId - 1861650570614018263
- participantId -
- noteAuthorParticipantId - 7192F7BB84387E03A0CE63281FCCE5162DBF8532F9DCB1AFF88F7F7291CB18B9 Participant Details
- createdAtMillis - 1732687058486
- tweetId - 1861643996818481289
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- A GLP-1 inhibitor does not exist as a distinct medical term, but it might be a confusion or reference to GLP-1 receptor agonists, which are medications used to treat type 2 diabetes and obesity. They bind to the GLP-1 receptor and activate it, enhancing the hormone's effects. https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/expert-answers/byetta/faq-20057955
Note Ratings
| rated at | rated by | |
| 2024-11-27 15:30:14 -0600 | Rating Details | |
| 2024-11-27 14:15:11 -0600 | Rating Details | |
| 2024-11-27 08:10:46 -0600 | Rating Details | |
| 2024-11-27 03:47:30 -0600 | Rating Details | |
| 2024-11-27 02:47:12 -0600 | Rating Details | |
| 2024-11-27 01:46:33 -0600 | Rating Details | |
| 2024-11-27 01:41:13 -0600 | Rating Details | |
| 2024-11-27 00:36:47 -0600 | Rating Details | |
| 2024-11-27 00:08:26 -0600 | Rating Details | |
| 2024-11-27 14:36:46 -0600 | Rating Details | |
| 2024-11-27 09:14:23 -0600 | Rating Details | |
| 2024-11-27 02:18:09 -0600 | Rating Details | |
| 2024-11-27 01:06:00 -0600 | Rating Details | |
| 2024-11-27 10:22:19 -0600 | Rating Details | |
| 2024-11-27 01:18:07 -0600 | Rating Details | |
| 2024-11-27 01:09:01 -0600 | Rating Details | |
| 2024-11-27 13:44:58 -0600 | Rating Details | |
| 2024-11-27 08:02:01 -0600 | Rating Details | |
| 2024-11-27 06:50:53 -0600 | Rating Details | |
| 2024-11-27 02:12:58 -0600 | Rating Details | |
| 2024-11-27 01:58:18 -0600 | Rating Details | |
| 2024-11-27 00:47:15 -0600 | Rating Details | |
| 2024-11-27 00:28:39 -0600 | Rating Details |